TORCH Multiplex Panels

  • BioPlex 2200 TORCH Testing

    The BioPlex 2200 System simplifies testing for congenital infections by combining eight independent tests into three panels for flexible and efficient testing.

    Contact a Specialist

  •  

BioPlex 2200 TORCH Testing – At a Glance

Torch Testing at a Glance

TORCH Testing for Congenital Infections

TORCH infections can lead to congenital infections and may cause adverse outcomes in fetuses and newborns. While these infections may not cause significant illness in healthy adults, they can cause severe complications if transmitted to a fetus during pregnancy.1

TORCH testing includes Toxoplasma gondii, rubella, cytomegalovirus, and herpes simplex virus. Testing patients before pregnancy or during the prenatal period determines the immune status of the mother and identifies infections early.

The BioPlex 2200 System’s comprehensive menu offers flexible options for TORCH testing, including ToRC IgG, ToRC IgM, and HSV-1 & HSV-2 IgG.

Congenital Infections

Infant holding mothers finger
  • Watch Our Labroots Webinar

    Role of Serology for Congenital Infections and Vaccine-Preventable Diseases in the Prenatal Setting

    In this educational webinar, our speakers provide an overview of congenital infections and the use of serological testing in detecting and preventing prenatal infections.

    Watch the webinar

  • Guest Speakers

    image of Alan Wu

    Alan Wu, PhD
    Chief of Clinical Chemistry
    and Toxicology Laboratories,
    San Francisco General Hospital

    image of Russel Neuner

    Russell Neuner, PhD
    Research and Development Manager,
    Clinical Immunology,
    Bio-Rad Laboratories

Efficiency of Multiplex Testing

  •  
    • Generate multiple results in a single test 
    • Consolidate test methods on a fully automated, random-access multiplex platform
    • Eliminate manual and batch testing
    • Reduce laboratory waste and optimize reagent storage
    • Decrease send out testing to improve turnaround time
  •  

Streamline TORCH Testing

Minimize laboratory effort

The BioPlex 2200 System uses multiplex technology to deliver more results with fewer tests.

  • Streamline BPTesting TORCH
  • Streamline TraditionalTesting TORCH
  • Confidence in Results

    • Verification of assay performance and result integrity in every test
    • Simplified workflow with full automation
    • Ready to use reagents, calibrators, and controls to minimize errors
    • Reliability in patient results driven by strong assay precision 
    • Strong agreement with CDC disease specific panels and quantitative test results correlated to WHO standards

More Results, Less Effort.

check mark icon

Flexibility in Testing

Easily order multiple assays from a single test kit

check mark icon

Increase Laboratory Efficiency

Consolidate eight individual tests into three multiplex panels to simplify laboratory workflow and minimize effort

check mark icon

Report Results Confidently

Ensure high quality results with full automation and verification of assay performance in every test

BioPlex 2200 System

  • bioplex 2200
  • bead tree
  • streamline bioplex
  • turnaround times
  • tla system
  • lis bioplex
BioPlex 2200 ToRC IgG

Toxoplasma, Rubella and Cytomegalovirus (ToRC)

BioPlex 2200 ToRC IgG

For simultaneous detection and differentiation of antibodies to Toxoplasma gondii, rubella and cytomegalovirus.

  • Toxoplasma gondii lgG (quantitative)
  • Rubella lgG (quantitative)
  • Cytomegalovirus lgG (qualitative)

Order now


Please contact your local sales office for any product questions.*

 
BioPlex ToRC IgM

Toxoplasma, Rubella and Cytomegalovirus (ToRC)

BioPlex 2200 ToRC IgM

For simultaneous detection and differentiation of antibodies to Toxoplasma gondii, rubella and cytomegalovirus.

  • Toxoplasma gondii lgM (qualitative)
  • Rubella lgM (qualitative)
  • Cytomegalovirus lgM (qualitative)

Order now


Please contact your local sales office for any product questions.*

 
BioPlex 2200 HSV-1 & HSV-2 IgG Panel

Herpes Simplex Virus

BioPlex 2200 HSV-1 & HSV-2 IgG

For simultaneous detection and differentiation of the two most clinically relevant HSV antibodies HSV-1 and HSV-2 IgG.

  • HSV-1 IgG
  • HSV-2 IgG

Order now


Please contact your local sales office for any product questions.*

References

  1. Neu N et al. (2015). TORCH infections. Clinics in perinatology 42, 77-103.
  2. Samies NL et al. (2021). Neonatal herpes simplex virus disease: updates and continued challenges. Clinics in perinatology 48, 263-274.
  3. Arnold KC and Flint CJ (2017). Cytomegalovirus, Parvovirus B19, Varicella Zoster, and Toxoplasmosis in Pregnancy. Obstetrics Essentials 199-207.

Disclaimer

*  These pages list our product offerings in these areas. Some products have limited regional availability. If you have a specific question about
    products available in your area, please contact your local sales office or representative.